Continuing Towards Optimization of Bladder Cancer Care in Canada: Summary of the Third Bladder Cancer Canada-Canadian Urological Association-Canadian Urologic Oncology Group (BCC-CUA-CUOG) Bladder Cancer Quality of Care Consensus Meeting

原文：2020年发布于 Can Urol Assoc J 14卷第3期 E115-E125  浏览量：332次 原文链接

作者： Third Bladder Cancer Canada-Canadian Urological Association-Canadian Urologic Oncology Group (BCC-CUA-CUOG)

归属分类：膀胱肿瘤临床实践指南

关键词： Bladder Cancer Care Consensus

文献简介

无

原文网址：https://pubmed.ncbi.nlm.nih.gov/32453694/

Current Management of Localized Muscle-invasive Bladder Cancer: a Consensus Guideline from the Genitourinary Medical Oncologists of Canada

Report from the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers. II. Molecular Pathology of Bladder Cancer: Progress and Challenges

热门文献

GSTM1 and GSTT1 polymorphisms are associated with increased bladder cancer risk: Evidence from updated meta-analysis

 Clin Invest Med 1427
Efficacy and toxicity in scheduled intravesical gemcitabine versus Bacille Calmette-Guerin for Ta and T1 bladder cancer: a systematic review and meta-analysis

 J Cancer Res Ther 39 卷第 6 期 975
吉西他滨较丝裂霉素治疗 TURBT 后非肌层浸润性膀胱癌的复发率低、毒副作用小 : 基于随机对照试验的荟萃分析

 PeerJ 60 卷第 5 期 972
Urinary human papilloma virus infection and bladder cancer risk: A systematic review and a prisma-compliant meta-analysis

 Int J Nurs Pract 13 卷第 4 期 900
Comparison of the prognosis of primary and progressive muscle-invasive bladder cancer after radical cystectomy: A systematic review and meta-analysis

 Oncotarget 841
Clinicopathological and Prognostic Value of Ki-67 Expression in Bladder Cancer: A Systematic Review and Meta-Analysis

 Bmc Urology 821
[Adjuvant radiotherapy after radical cystectomy for muscle-invasive bladder cancer]

 Front Endocrinol (Lausanne) 13 卷第 11 期 807
Meta-analysis of a 10-plex urine-based biomarker assay for the detection of bladder cancer

 Eur J Nutr 11 卷第 2 期 800
经尿道钬激光切除与经尿道电切治疗非肌层浸润性膀胱肿瘤疗效比较的荟萃分析

 Immunotherapy 9 卷第 21 期 771
Gemcitabine/cisplatin versus methotrexate/vinblastine/doxorubicin/cisplatin for muscle-invasive bladder cancer: A systematic review and meta-analysis

 Urol Oncol 286 卷第 22 期 769

Continuing Towards Optimization of Bladder Cancer Care in Canada: Summary of the Third Bladder Cancer Canada-Canadian Urological Association-Canadian Urologic Oncology Group (BCC-CUA-CUOG) Bladder Cancer Quality of Care Consensus Meeting

原文：2020年发布于 Can Urol Assoc J 14卷第3期 E115-E125  浏览量：332次 原文链接

文献简介

上一篇

Current Management of Localized Muscle-invasive Bladder Cancer: a Consensus Guideline from the Genitourinary Medical Oncologists of Canada

下一篇

Report from the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers. II. Molecular Pathology of Bladder Cancer: Progress and Challenges

GSTM1 and GSTT1 polymorphisms are associated with increased bladder cancer risk: Evidence from updated meta-analysis

Efficacy and toxicity in scheduled intravesical gemcitabine versus Bacille Calmette-Guerin for Ta and T1 bladder cancer: a systematic review and meta-analysis

吉西他滨较丝裂霉素治疗 TURBT 后非肌层浸润性膀胱癌的复发率低、毒副作用小 : 基于随机对照试验的荟萃分析

Urinary human papilloma virus infection and bladder cancer risk: A systematic review and a prisma-compliant meta-analysis

Comparison of the prognosis of primary and progressive muscle-invasive bladder cancer after radical cystectomy: A systematic review and meta-analysis

Clinicopathological and Prognostic Value of Ki-67 Expression in Bladder Cancer: A Systematic Review and Meta-Analysis

[Adjuvant radiotherapy after radical cystectomy for muscle-invasive bladder cancer]

Meta-analysis of a 10-plex urine-based biomarker assay for the detection of bladder cancer

经尿道钬激光切除与经尿道电切治疗非肌层浸润性膀胱肿瘤疗效比较的荟萃分析

Gemcitabine/cisplatin versus methotrexate/vinblastine/doxorubicin/cisplatin for muscle-invasive bladder cancer: A systematic review and meta-analysis

Continuing Towards Optimization of Bladder Cancer Care in Canada: Summary of the Third Bladder Cancer Canada-Canadian Urological Association-Canadian Urologic Oncology Group (BCC-CUA-CUOG) Bladder Cancer Quality of Care Consensus Meeting

原文：2020年 发布于 Can Urol Assoc J 14卷 第3期 E115-E125  浏览量：332次 原文链接

文献简介

上一篇

下一篇

原文：2020年发布于 Can Urol Assoc J 14卷第3期 E115-E125  浏览量：332次 原文链接